Global Bladder Cancer Market Research and Forecast 2018-2023 Global Bladder Cancer Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023
GLOBAL BLADDER CANCER MARKET INSIGHTS Global Bladder cancer market is a tumour, which starts in the cells of the bladder. Factors such as increasing incidence of bladder cancer fuel the growth of the market. As per American Medical Association, a growth of 31% in global bladder cancer has been recorded in 2015 as compared to 2005 Furthermore, rise in awareness about cancer and their available therapies, increasing healthcare expenditure, growing smoking and tobacco consumption are also motivating the market. Sometimes, bladder cancer is asymptomatic in nature, due to which patients can’t get diagnosed in the due course of time. It is the major restrain for the market. Cisplatin is a generic drug available for the treatment of bladder cancer. It is being manufactured all across the globe. Besides that, various companies are getting FDA approval of new drugs for bladder cancer and numerous drugs are being sent for clinical trials. Hence, innovation in drug development, subsequent technological advancements, and pipeline products are expected to find immense opportunity during the forecast period. For Related Reports: Healthcare Industry
BLADDER CANCER MARKET INSIGHTS The global bladder cancer market is analyzed on the basis of geographical regions that are contributing significantly towards the growth of the market. The market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate in the global bladder cancer market owing to high prevalence of bladder cancer in the US. The major factors that are augmenting the market are high prevalence of bladder cancer diseases, high healthcare expenditure, and government policies. Asia Pacific region is expected to have a considerable market growth during the forecast period. Major countries contributing in the region are India, China, and Japan. Large patients base, continuous increment in economy &healthcare facilities are the major factors for the growth of the market in the region. The major companies active in the market are AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Epocrates, Genentech, GlaxoSmithKline, Roche, Merck & Co, Novartis, Pfizer and so on. These companies are focusing on product innovations, expansions, finding new markets or innovating their core competency to expand their individual market share. The report includes detailed insights into market overview, strategic recommendations, key company analysis, key findings, analyst insights, market determinants, market segmentation and company profiling of the market.
Bladder cancer market Segmentation : Global Bladder Cancer market is segmented on the basis of regional outlook and following segments: Global Bladder Cancer Market Research and Analysis, By Cancer Type Global Bladder Cancer Market Research and Analysis, By Diagnosis Global Bladder Cancer Market Research and Analysis, By Therapy Global Bladder Cancer Market Research and Analysis, By Region
THE REPORT COVER Comprehensive research methodology of Global Bladder Cancer Market. This report also includes detailed and extensive market overview with key analyst insights. Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the Global Bladder Cancer Market. Insights about market determinants which are stimulating the Global Bladder Cancer Market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players.
For More updated Follow: LinkedIn
Table Of Content (Global Bladder Cancer Market) REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS 1.2. MARKET BREAKDOWN 1.2.1. BY SEGMENTS 1.2.2. BY GEOGRAPHY 1.2.3. BY STAKEHOLDERS 1.2.4. EXCEPTIONS
Table Of Content MARKET OVERVIEW AND INSIGHTS 2.1. DEFINITION 2.2. PATENT ANALYSIS 2.3. ANALYST INSIGHTS & CURRENT MARKET TRENDS 2.3.1. KEY FINDINGS 2.3.2. RECOMMENDATION 2.3.3. CONCLUSION 2.4. REGULATION 2.4.1.1. UNITED STATES 2.4.1.2. EUROPEAN UNION 2.4.1.3. CHINA 2.4.1.4. INDIA
Table Of Content MARKET DETERMINANT 3.1. MOTIVATORS 3.1.1. RISE IN AWARENESS ABOUT CANCER DISEASES AND THEIR AVAILABLE THERAPIES 3.1.2. INCREASING HEALTHCARE EXPENDITURE 3.1.3. INCREASING INCIDENCE OF BLADDER CANCER 3.1.4. GROWING SMOKING AND TABACO CONSUMPTION 3.1.5. HIGH PREVALENCE IN GERIATRIC POPULATION & INCREASING GERIATRIC POPULATION BASE 3.2. RESTRAINTS 3.2.1. ASYMPTOMATIC NATURE OF THE DISEASE 3.3. OPPORTUNITIES 3.3.1. INNOVATION IN DRUG DEVELOPMENT, AND SUBSEQUENT TECHNOLOGICAL ADVANCEMENTS & PIPE LINE PRODUCT
Table Of Content (MARKET SEGMENTATION) 4.1. GLOBAL BLADDER CANCER MARKET, BY CANCER TYPE 4.1.1. TRANSITIONAL CELL BLADDER CANCER/ UROTHELIAL CARCINOMA 4.1.2. SQUAMOUS CELL BLADDER CANCER 4.1.3. ADENOCARCINOMA 4.1.4. OTHER RARE TYPES (SARCOMAS, CARCINOMA IN SITU) 4.2. GLOBAL BLADDER CANCER MARKET, BY DIAGNOSIS METHOD 4.2.1. CYSTOSCOPY 4.2.2. BIOPSY 4.2.3. URINALYSIS 4.2.4. URINE CYTOLOGY 4.2.5. INTRAVENOUS PYELOGRAM (IVP) 4.2.6. OTHER 4.3. GLOBAL BLADDER CANCER MARKET, BY THERAPY 4.3.1. CHEMOTHERAPY 4.3.2. IMMUNOTHERAPY 4.3.3. RADIATION THERAPY 4.3.4. SURGERY 4.3.5. OTHER (PD-1 MODULATORS, RADICAL CYSTECTOMY, CLINICAL TRIAL, INTRAVESICAL THERAPY)
Table Of Content COMPETITIVE LANDSCAPE 5.1. KEY STRATEGIES 5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS 6.1. NORTH AMERICAN 6.1.1. UNITED STATES 6.1.2. CANADA 6.2. EUROPE 6.2.1. UK 6.2.2. GERMANY 6.2.3. SPAIN 6.2.4. FRANCE 6.2.5. ITALY 6.3. APAC 6.3.1. INDIA 6.3.2. CHINA 6.3.3. JAPAN 6.3.4. REST OF APAC 6.4. REST OF THE WORLD
Table Of Content 7.1. ASTRAZENECA PLC 7.2. BRISTOL-MYERS SQUIBB 7.3. CELGENE CORPORATION 7.4. ELI LILLY AND CO 7.5. EMD SERONO, INC 7.6. ENDO INTERNATIONAL PLC 7.7. EPOCRATES, INC. 7.8. GENENTECH, INC 7.9. GLAXOSMITHKLINE PLC 7.10. HOFFMANN-LA ROCHE AG 7.11. MERCK & CO., INC. 7.12. NOVARTIS INTERNATIONAL AG 7.13. NUCLEIX LTD 7.14. PFIZER INC 7.15. TARIS BIOMEDICAL LLC 7.16. SPECTRUM PHARMACEUTICALS, INC
(COMPANY PROFILES)
CONTACT US CORPORATE OFFICE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010
+1-646-755-7667
(Global)
+91-7803040404
(India)
info@omrglobal.com, Support@omrglobal.com www.omrglobal.com/ For Full Reports Available at: Global Bladder Cancer Market
We Analyze Future Simply